Tempest Therapeutics (TPST)

• Market cap: $11.5M
• 1 day: -2.9%
• 5 days: 68.35%
• 1 month: 65.96%
• 3 months: -48.68%
• 6 months: -37.27%
• Year to date: 58.11%
• 1 year: -61.26%
• 5 years: -98.94%
• 10 years: -99.97%
• Sector: Healthcare
• Industry: Biotechnology

About: Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic product candidates are TPST-1120 and TPST-1495 which are clinical-stage molecules designed to inhibit their respective targets.

Employees: 5